Global Contrast Injection Lines Market Insights and Forecast to 2028

Contrast injection lines help to administrate contrast dye intravenously by injections. Contrast injection lines are configured for both high and low contrast injections.
Market Analysis and Insights: Global Contrast Injection Lines Market
Due to the COVID-19 pandemic, the global Contrast Injection Lines market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, High Pressure Contrast Injection Line accounting for % of the Contrast Injection Lines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Contrast Injection Lines market size is valued at US$ million in 2021, while the US and Europe Contrast Injection Lines are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Contrast Injection Lines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Contrast Injection Lines include Angiodynamics, Argon Medical Devices, Merit Medical Systems, George Philips Medical Engineering and Shenzhen X-Way Medical Technology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Contrast Injection Lines Scope and Segment
Contrast Injection Lines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Contrast Injection Lines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
High Pressure Contrast Injection Line
Low Pressure Contrast Injection Line
Segment by Application
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
By Company
Angiodynamics
Argon Medical Devices
Merit Medical Systems
George Philips Medical Engineering
Shenzhen X-Way Medical Technology
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E